1) Akbarian S, Huang HS:Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 52:293-304, 2006
2) Bernstein HG, Steiner J, Guest PC et al:Glial cells as key players in schizophrenia pathology:Recent insights and concepts of therapy. Schizophr Res 161:4-18, 2015
3) Cao H, Sekiya M, Ertunc ME, et al:Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. Cell Metab 17:768-778, 2013
4) Furuhashi M, Hotamisligil GS:Fatty acid-binding proteins:role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7:489-503, 2008
5) Hakak Y, Walker JR, Li C, et al:Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98:4746-4751, 2001
6) Hashimoto T, Bazmi HH, Mirnics K, et al:Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry 165:479-489, 2008
7) Horváth S, Janka Z, Mirnics K:Analyzing schizophrenia by DNA microarrays. Biol Psychiatry 69:157-162, 2011
8) Lewis DA, Hashimoto T, Morris HM:Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia. Neurotox Res 14:237-248, 2008
9) Maekawa M, Owada Y, Yoshikawa T:Role of polyunsaturated fatty acids and fatty acid binding protein in the pathogenesis of schizophrenia. Curr Pharm Des 17:168-175, 2011
10) Maekawa M, Yamada K, Toyoshima M, et al:Utility of Scalp Hair Follicles as a Novel Source of Biomarker Genes for Psychiatric Illnesses. Biol Psychiatry 78:116-125, 2015
11) Schwede M, Garbett K, Mirnics K, et al:Genes for endosomal NHE6 and NHE9 are misregulated in autism brains. Mol Psychiatry 19:277-279, 2014
12) Shimamoto C, Ohnishi T, Maekawa M, et al:Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies. Hum Mol Genet 23:6495-6511, 2014
13) Sokolov BP:Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies? Int J Neuropsychopharmacol 10:547-555, 2007
14) Stenn KS, Paus R:Controls of hair follicle cycling. Physiol Rev 81:449-494, 2001
15) Tkachev D, Mimmack ML, Ryan MM, et al:Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362:798-805, 2003
16) Voineagu I, Wang X, Johnston P, et al:Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474:380-384, 2011
17) Wagner JA:Strategic approach to fit-for-purpose biomarkers in drug development. Annu Rev Pharmacol Toxicol 48:631-651, 2008
18) Watanabe A, Toyota T, Owada Y, et al:Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol 5:e297, 2007